Cadrenal Therapeutics, Inc. Common Stock (CVKD) — Financial statements
Income statement, balance sheet, and cash flow for Cadrenal Therapeutics, Inc. Common Stock — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue & Gross Profit | |||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.00 | 0.00 | 0.00↓100.0% | 0.00 | |
| Gross Profit | 0.00 | 0.00 | 0.00↑100.0% | -0.00 | |
| Operating Expenses | |||||
| R&D Expenses | 4↓2.5% | 4↑3.0% | 4↑938.9% | 0.39 | |
| General & Administrative Expenses | 9↑38.5% | 7↑90.3% | 4 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 9↑38.5% | 7↑90.3% | 4↑53.8% | 2 | |
| Other Expenses | 0.01↑265.6% | 0.00↓5.1% | 0.00 | 0.00 | |
| Operating Expenses | 13↑22.8% | 11↑43.6% | 8↑182.7% | 3 | |
| Total Costs & Expenses | 13↑22.8% | 11↑43.6% | 8↑182.5% | 3 | |
| Operating Results | |||||
| Operating Income | -13↓22.8% | -11↓43.6% | -8↓182.5% | -3 | |
| Depreciation & Amortization | 0.01↑265.6% | 0.00↓5.1% | 0.00↑56.4% | 0.00 | |
| EBITDA | -13↓26.4% | -11↓27.7% | -8↓26.2% | -7 | |
| EBIT | -13↓26.4% | -11↓27.7% | -8↓26.2% | -7 | |
| Interest & Other Income | |||||
| Net Interest Income | 0.22↓27.6% | 0.31↑33.3% | 0.23↑316.6% | -0.11 | |
| Interest Income | 0.22↓27.6% | 0.31↑24.2% | 0.25 | 0.00 | |
| Interest Expense | 0.00 | 0.00↓100.0% | 0.02↓84.0% | 0.11 | |
| Non-Operating Income | 0.00↑100.0% | -0.31↓143.7% | 0.71↓81.9% | 4 | |
| Other Income / Expenses | 0.22↓27.6% | 0.31↑142.7% | -0.72↑82.0% | -4 | |
| Income Before Tax | -13↓24.3% | -11↓27.5% | -8↓24.5% | -7 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | |||||
| Net Income from Continuing Operations | -13↓24.3% | -11↓27.5% | -8↓24.5% | -7 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -13↓24.3% | -11↓27.5% | -8↓24.5% | -7 | |
| Bottom-Line Net Income | -13↓24.3% | -11↓27.5% | -8↓24.5% | -7 | |
| EPS (Basic) | -6.64↑23.9% | -8.73↑9.3% | -9.63↓11.2% | -8.66 | |
| EPS (Diluted) | -6.64↑23.9% | -8.73↑9.3% | -9.63↓11.2% | -8.66 | |
| Weighted Average Shares | 2↑63.5% | 1↑40.5% | 0.87↑11.9% | 0.78 | |
| Weighted Average Diluted Shares | 2↑63.5% | 1↑40.5% | 0.87↑11.9% | 0.78 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.